Insurance Coverage & Financial Assistance

84% of patients have $0 financial responsibility*
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid and commercial insurance. Patient cost-sharing amounts, including deductibles and copays will vary by plan and coverage type. Only the patient’s insurer can confirm if and how the Oncotype DX GPS test will be covered.
91% of Oncotype DX Genomic Prostate Score test patients have a financial responsibility of less than $100*
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid and commercial insurance. Patients with high-deductible plans may receive a bill for most or all the cost of the Oncotype DX GPS test if they have not satisfied their deductible.

Insurance coverage & billing information

Exact Sciences is committed to supporting patient access to the Oncotype DX Genomic Prostate Score (GPS) test to help patients in making informed decisions about their treatment. We handle all insurance billing on behalf of patients. If a patient’s insurance denies payment for the Oncotype DX GPS test, Exact Sciences pursues an appeal on the patient’s behalf when appropriate, and if appeal options are available.

A patient’s financial responsibility depends on his or her specific insurance plan. Plans may include high deductibles (an amount paid by the patient before insurance pays), co-pays (a fixed amount paid per visit or treatment) and non-covered charges.

The Oncotype DX GPS test is covered by many commercial insurances. Patients are strongly encouraged to contact their insurer for specific coverage details. The Oncotype DX GPS test is performed and billed by Genomic Health, Inc., an Exact Sciences Laboratory, and reported on claims with the unique proprietary laboratory analysis (PLA) code, 0047U.

Patients with fee for service (FFS) Medicare will have $0 financial responsibility if they meet coverage requirements. Patients with Medicare Advantage, which is provided by a commercial insurance company, may have different financial responsibility amounts than patients with fee for service (FFS) Medicare.

Financial assistance program

Financial assistance is available for eligible patients who are uninsured or concerned about their ability to pay for testing.

To ensure that patients can focus on their health, Exact Sciences created the Genomic Access Program (GAP). GAP helps eligible patients understand other payment options available for the Oncotype DX GPS test.

To learn more, patients should contact our Customer Service team by phone at 888-ONCOTYPE (888-662-6897, option 2), or by email.

Exact Sciences strongly encourages patients to contact their insurer when they have questions about their benefits. Regardless of network status, all commercial insurance coverage is governed by an insurer’s medical policy and patient benefit type.

* The numbers cited are based on historical patient billing data from 1/02/2020 to 11/03/2020. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages patients to contact their insurer with questions about Oncotype DX GPS test coverage.
Making cancer care smarter.®
X

We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.